Status:
COMPLETED
The Utility of Lung Clearance Index in Ethnic Groups and in Disease
Lead Sponsor:
Birmingham Women's and Children's NHS Foundation Trust
Conditions:
Healthy Children
Bronchiectasis Adult
Eligibility:
All Genders
6-12 years
Phase:
NA
Brief Summary
Introduction: Non-CF, non-PCD bronchiectasis in children is a chronic, suppurative lung disease diagnosed by high resolution computed tomography (HRCT) imaging of the lungs. Spirometry can be abnorma...
Detailed Description
Rationale / Hypothesis: Hypothesis 1 Having established normative ranges helps support interpretation of lung function testing which is key to their value as an investigation. With LCI, it is import...
Eligibility Criteria
Inclusion
- Healthy children
Exclusion
- Those with underlying respiratory/systemic disease/ prematurity
Key Trial Info
Start Date :
March 11 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT05989360
Start Date
March 11 2020
End Date
September 1 2022
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham Children's Hospital
Birmingham, West Midlands, United Kingdom, B4 6NH